CV Sciences Inc (CVSI): "During the clinical trials for the CBD-...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	49
Posts	2419
Boards Moderated	0
Alias Born	12/31/2014

CashMoneyCarl

Re: I-Glow post# 52126

Friday, 07/12/2019 4:31:18 PM

Friday, July 12, 2019 4:31:18 PM

"During the clinical trials for the CBD-based epilepsy drug Epidiolex, which was approved for the U.S. market just last year, researchers found the medication caused liver toxicity in some patients."

You are only posting half the facts. What about the part about dosage? You are posting out of context.

A link to the report you are referring too would be a nice touch.. is that too much to ask for?

A fool and his money is a friend indeed.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CVSI News

Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM